The largest database of trusted experimental protocols

2 5 dimethoxy 4 iodoamphetamine

Manufactured by Merck Group
Sourced in United States, Sao Tome and Principe

2,5-Dimethoxy-4-iodoamphetamine is a chemical compound used for research purposes in analytical chemistry and pharmacology laboratories. It is a substituted amphetamine that can be utilized as a reference standard or analytical tool. The core function of this product is to serve as a research chemical for scientific investigation, without extrapolation on intended use.

Automatically generated - may contain errors

2 protocols using 2 5 dimethoxy 4 iodoamphetamine

1

Investigating CRF and 5-HT2R Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
2,5-Dimethoxy-4-iodoamphetamine, H-89, Forskolin and BIS were obtained from Sigma-Aldrich Co., St. Louis, MO, USA. CRF, antisauvagine-30 and antalarmin were obtained from Tocris Biosciences, Ellisville, MO, USA. Tat-CRFR1-CT peptide was obtained from CanPeptide, Inc., Pointe-claire, QC, Canada. The Tat-CRFR1-CT sequence used was YGRKKRRQRR-PTRVSFHSIKQSTAV. This peptide has been shown previously to prevent the functional synergism between CRFR1 and 5-HT2Rs (Magalhaes et al., 2010 (link)). Di-4-ANEPPS stock solution was prepared in alcohol and cremophore-EL solution which can be stored at 4°C for 2 months. FBS and ACSF were added on the day of experiment. CRF stock was dissolved in HBSS and milli-Q water mixture. DOI was prepared in alcohol and Milli-Q water. Forskolin, H-89, BIS, antalarmin, antisauvagine-30, and PMA stock solutions were prepared in dimethyl sulfoxide (DMSO). All the stock solutions were made 1000 times more concentrated than working concentrations.
+ Open protocol
+ Expand
2

Pharmacological Modulation of 5-HT Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The injectable anesthetic (+/−)-ketamine and the mixed 5-HT2A/2C receptor agonist (+/−)2,5-Dimethoxy-4-iodoamphetamine (DOI) (Fantegrossi et al., 2008 (link)) were purchased from Sigma-Aldrich (St. Louis, MO) and dissolved in saline. The selective 5-HT2C receptor antagonist, SB-242084 (Kennett et al., 1997 (link)), was purchased from SigmaAldrich (St. Louis, MO) and dissolved in 5% Tween 80, 5% ethanol, and brought to final volume in saline. The selective 5-HT2C receptor agonist, WAY-163909 (Grauer et al., 2009 (link); Marquis et al., 2007 (link)), was provided as a gift from Pfizer (New York, NY) and dissolved in 5% Tween 80 and brought to final volume in saline. All injections were administered intraperitoneally at a volume of 0.01 ml of the drug solution per g body weight of each mouse. All doses are reported in the salt form.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!